Multimodal treatment strategies for elderly patients with head and neck cancer

Cancer Treatment Reviews

Volumn 40, Issue 3, 2014, Pages 465-475

  Sarris, Evangelos G ^a   Harrington, Kevin J ^b   Saif, Muhammad W ^c   Syrigos, Konstantinos N ^a  

^a SOTIRIA GENERAL HOSPITAL   (Greece)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Elderly; Geriatric evaluation; Head and neck cancer; Multidisciplinary approach; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; DISEASE SPECIFIC SURVIVAL; DNA REPAIR; ELDERLY CARE; EPIDEMIOLOGICAL DATA; EXTERNAL BEAM RADIOTHERAPY; FUNCTIONAL STATUS; GERIATRIC ASSESSMENT; GERIATRIC CARE; HEAD AND NECK CANCER; HEART OUTPUT; HUMAN; HYPOPHARYNX CANCER; IMMUNOSURVEILLANCE; INTENSITY MODULATED RADIATION THERAPY; MOUTH CANCER; MOUTH SQUAMOUS CELL CARCINOMA; NECK DISSECTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OROPHARYNX CANCER; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; PROTON THERAPY; RADIATION DOSE DISTRIBUTION; RADIOIMMUNOTHERAPY; REVIEW; SECOND CANCER; STEREOTACTIC BODY RADIATION THERAPY; TONSIL CANCER; TREATMENT PLANNING;

ELDERLY; GERIATRIC EVALUATION; HEAD AND NECK CANCER; MULTIDISCIPLINARY APPROACH; TREATMENT;

AGE FACTORS; AGED; COMBINED MODALITY THERAPY; HEAD AND NECK NEOPLASMS; HUMANS; PRACTICE GUIDELINES AS TOPIC; TREATMENT OUTCOME;

EID: 84892881097     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2013.10.007     Document Type: Review

References (141)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005, 55:74-108.
2. Jemal A., Siegel R., Ward E., Murray T., Xu J., Thun M.J. Cancer statistics, 2007. CA Cancer J Clin 2007, 57:43-66.
3. Syrigos K.N., Karachalios D., Karapanagiotou E.M., Nutting C.M., Manolopoulos L., Harrington K.J. Head and neck cancer in the elderly: an overview on the treatment modalities. Cancer Treat Rev 2009, 35:237-245.
4. Kruse A.L., Bredell M., Luebbers H.T., Gratz K.W. Head and neck cancer in the elderly: a retrospective study over 10 years. Head Neck Oncol 2010, 2:25.
5. Huang S.H., O'Sullivan B., Waldron J., et al. Patterns of care in elderly head-and-neck cancer radiation oncology patients: a single-center cohort study. Int J Radiat Oncol Biol Phys 2011, 79:46-51.
6. Smith B.D., Smith G.L., Hurria A., Hortobagyi G.N., Buchholz T.A. Future of cancer incidence in the United States: burdens upon an aging, changing nation. J Clin Oncol 2009, 27:2758-2765.
7. Finnish Cancer Registry. Available from: <>. http://www.cancerregistry.fi.
8. Argiris A., Karamouzis M.V., Raben D., Ferris R.L. Head and neck cancer. Lancet 2008, 371:1695-1709.
9. Argiris A., Eng C. Epidemiology, staging, and screening of head and neck cancer. Cancer Treat Res 2003, 114:15-60.
10. Pallis A.G., Fortpied C., Wedding U., et al. EORTC elderly task force position paper: approach to the older cancer patient. Eur J Cancer 2010, 46:1502-1513.
11. Parker S.L., Tong T., Bolden S., Wingo P.A. Cancer statistics, 1997. CA Cancer J Clin 1997, 47:5-27.
12. Lewis J.H., Kilgore M.L., Goldman D.P., Trimble E.L., Kaplan R., Montello M.J., et al. Participation of patients 65years of age or older in cancer clinical trials. J Clin Oncol 2003, 21(7):1383-1389.
13. Talarico L., Chen G., Pazdur R. Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration. J Clin Oncol 2004, 22(22):4626-4631.
14. Italiano A., Ortholan C., Dassonville O., et al. Head and neck squamous cell carcinoma in patients aged > or = 80years: patterns of care and survival. Cancer 2008, 113:3160-3168.
15. Sarini J., Fournier C., Lefebvre J.L., Bonafos G., Van J.T., Coche-Dequeant B. Head and neck squamous cell carcinoma in elderly patients: a long-term retrospective review of 273 cases. Arch Otolaryngol Head Neck Surg 2001, 127:1089-1092.
16. Pignon J.P., le Maître A., Maillard E., Bourhis J. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009, 92:4-14.
17. Ortholan C., Lusinchi A., Italiano A., et al. Oral cavity squamous cell carcinoma in 260 patients aged 80years or more. Radiother Oncol 2009, 93:516-523.
18. Koch W.M., Patel H., Brennan J., Boyle J.O., Sidransky D. Squamous cell carcinoma of the head and neck in the elderly. Arch Otolaryngol Head Neck Surg 1995, 121:262-265.
19. Leon X., Quer M., Agudelo D., et al. Influence of age on laryngeal carcinoma. Ann Otol Rhinol Laryngol 1998, 107:164-169.
20. Ang K.K., Harris J., Wheeler R., et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010, 363:24-35.
21. Boscolo-Rizzo P., Del Mistro A., Bussu F., Lupato V., Baboci L., Almadori G., et al. New insights into human papillomavirus-associated head and neck squamous cell carcinoma. Acta Otorhinolaryngol Ital 2013, 33(2):77-87.
22. Dayyani F., Etzel C.J., Liu M., Ho C.H., Lippman S.M., Tsao A.S. Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC). Head Neck Oncol 2010, 29(2):15.
23. Ragin C.C., Taioli E. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 2007, 121(8):1813-1820.
24. Lusinchi A., Bourhis J., Wibault P., Le Ridant A.M., Eschwege F. Radiation therapy for head and neck cancers in the elderly. Int J Radiat Oncol Biol Phys 1990, 18:819-823.
25. Jones A.S., Husband D., Rowley H. Radical radiotherapy for squamous cell carcinoma of the larynx, oropharynx and hypopharynx: patterns of recurrence, treatment and survival. Clin Otolaryngol Allied Sci 1998, 23:496-511.
26. Hirano M., Mori K. Management of cancer in the elderly: therapeutic dilemmas. Otolaryngol Head Neck Surg 1998, 118:110-114.
27. Derks W., de Leeuw J.R., Hordijk G.J., Winnubst J.A. Reasons for non-standard treatment in elderly patients with advanced head and neck cancer. Eur Arch Otorhinolaryngol 2005, 262:21-26.
28. Bernardi D., Barzan L., Franchin G., et al. Treatment of head and neck cancer in elderly patients: state of the art and guidelines. Crit Rev Oncol Hematol 2005, 53:71-80.
29. Clayman G.L., Eicher S.A., Sicard M.W., Razmpa E., Goepfert H. Surgical outcomes in head and neck cancer patients 80years of age and older. Head Neck 1998, 20:216-223.
30. Airoldi M., Cortesina G., Giordano C., et al. Postoperative adjuvant chemoradiotherapy in older patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2004, 130:161-166.
31. Argiris A., Li Y., Murphy B.A., Langer C.J., Forastiere A.A. Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapy. J Clin Oncol 2004, 22:262-268.
32. Bhattacharyya N. A matched survival analysis for squamous cell carcinoma of the head and neck in the elderly. Laryngoscope 2003, 113:368-372.
33. Extermann M., Aapro M., Bernabei R., et al. Use of comprehensive geriatric assessment in older cancer patients: recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 2005, 55:241-252.
34. Balducci L., Beghe' C. Cancer and age in the USA. Crit Rev Oncol Hematol 2001, 37:137-145.
35. Syrigos K.N., Karapanagiotou E., Charpidou A., et al. Biweekly administration of docetaxel and gemcitabine for elderly patients with advanced non-small cell lung cancer: a phase II study. J Chemother 2007, 19:438-443.
36. Extermann M., Overcash J., Lyman G.H., Parr J., Balducci L. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 1998, 16:1582-1587.
37. Priebe H.J. The aged cardiovascular risk patient. Br J Anaesth 2000, 85:763-778.
38. Lakatta E.G. Cardiovascular aging research: the next horizons. J Am Geriatr Soc 1999, 47:613-625.
39. Paleri V., Wight R.G., Silver C.E., et al. Comorbidity in head and neck cancer: a critical appraisal and recommendations for practice. Oral Oncol 2010, 46:712-719.
40. Bond S.M., Dietrich M.S., Murphy B.A. Association of age and symptom burden in patients with head and neck cancer. ORL Head Neck Nurs 2011, 29:8-14.
41. Murphy B.A., Ridner S., Wells N., Dietrich M. Quality of life research in head and neck cancer: a review of the current state of the science. Crit Rev Oncol Hematol 2007, 62:251-267.
42. Sanabria A., Carvalho A.L., Vartanian J.G., Magrin J., Ikeda M.K., Kowalski L.P. Factors that influence treatment decision in older patients with resectable head and neck cancer. Laryngoscope 2007, 117:835-840.
43. El-Deiry M.W., Futran N.D., McDowell J.A., Weymuller E.A., Yueh B. Influences and predictors of long-term quality of life in head and neck cancer survivors. Arch Otolaryngol Head Neck Surg 2009, 135:380-384.
44. Terrell J.E., Ronis D.L., Fowler K.E., et al. Clinical predictors of quality of life in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 2004, 130:401-408.
45. Gourin C.G., Boyce B.J., Vaught C.C., Burkhead L.M., Podolsky R.H. Effect of comorbidity on post-treatment quality of life scores in patients with head and neck squamous cell carcinoma. Laryngoscope 2009, 119:907-914.
46. Piccirillo J.F., Tierney R.M., Costas I., Grove L., Spitznagel E.L. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 2004, 291:2441-2447.
47. Wan L.S., Lee T.F., Chien C.Y., Chao P.J., Tsai W.L., Fang F.M. Health-related quality of life in 640 head and neck cancer survivors after radiotherapy using EORTC QLQ-C30 and QLQ-H&N35 questionnaires. BMC Cancer 2011, 11:128.
48. Fang F.M., Liu Y.T., Tang Y., Wang C.J., Ko S.F. Quality of life as a survival predictor for patients with advanced head and neck carcinoma treated with radiotherapy. Cancer 2004, 100:425-432.
49. Gourin C.G., McAfee W.J., Neyman K.M., Howington J.W., Podolsky R.H., Terris D.J. Effect of comorbidity on quality of life and treatment selection in patients with squamous cell carcinoma of the head and neck. Laryngoscope 2005, 115:1371-1375.
50. Peters T.T., van der Laan B.F., Plaat B.E., Wedman J., Langendijk J.A., Halmos G.B. The impact of comorbidity on treatment-related side effects in older patients with laryngeal cancer. Oral Oncol 2011, 47:56-61.
51. Borggreven P.A., Verdonck-de Leeuw I.M., Muller M.J., et al. Quality of life and functional status in patients with cancer of the oral cavity and oropharynx: pretreatment values of a prospective study. Eur Arch Otorhinolaryngol 2007, 264:651-657.
52. Oozeer N.B., Benbow J., Downs C., Kelly C., Welch A., Paleri V. The effect of comorbidity on quality of life during radiotherapy in head and neck cancer. Otolaryngol Head Neck Surg 2008, 139:268-272.
53. Sanabria A., Carvalho A.L., Vartanian J.G., Magrin J., Ikeda M.K., Kowalski L.P. Comorbidity is a prognostic factor in elderly patients with head and neck cancer. Ann Surg Oncol 2007, 14:1449-1457.
54. Bernabei R., Venturiero V., Tarsitani P., Gambassi G. The comprehensive geriatric assessment: when, where, how. Crit Rev Oncol Hematol 2000, 33:45-56.
55. Metges J.P., Eschwege F., de Crevoisier R., Lusinchi A., Bourhis J., Wibault P. Radiotherapy in head and neck cancer in the elderly: a challenge. Crit Rev Oncol Hematol 2000, 34:195-203.
56. Lalami Y., de Crevoisier G., Bernard-Marty C., Awada A. Management of head and neck cancer in elderly patients. Drugs Aging 2009, 26:571-583.
57. Luciani A., Ascione G., Bertuzzi C., et al. Detecting disabilities in older patients with cancer: comparison between comprehensive geriatric assessment and vulnerable elders survey-13. J Clin Oncol 2010, 28:2046-2050.
58. Balducci L., Extermann M. Management of cancer in the older person: a practical approach. Oncologist 2000, 5:224-237.
59. Ortholan C., Benezery K., Dassonville O., et al. A specific approach for elderly patients with head and neck cancer. Anticancer Drugs 2011, 22:647-655.
60. Morgan R.F., Hirata R.M., Jaques D.A., Hoopes J.E. Head and neck surgery in the aged. Am J Surg 1982, 144:449-451.
61. McGuirt W.F., Loevy S., McCabe B.F., Krause C.J. The risks of major head and neck surgery in the aged population. Laryngoscope 1977, 87:1378-1382.
62. Zabrodsky M., Calabrese L., Tosoni A., et al. Major surgery in elderly head and neck cancer patients: immediate and long-term surgical results and complication rates. Surg Oncol 2004, 13:249-255.
63. Laccourreye O., Brasnu D., Perie S., Muscatello L., Menard M., Weinstein G. Supracricoid partial laryngectomies in the elderly: mortality, complications, and functional outcome. Laryngoscope 1998, 108:237-242.
64. Teymoortash A., Wulf H., Werner J.A. Head and neck cancer surgery in the elderly. Laryngorhinootologie 2002, 81:293-298.
65. Jones A.S., Beasley N., Houghton D., Husband D.J. The effects of age on survival and other parameters in squamous cell carcinoma of the oral cavity, pharynx and larynx. Clin Otolaryngol Allied Sci 1998, 23:51-56.
66. Boruk M., Chernobilsky B., Rosenfeld R.M., Har-El G. Age as a prognostic factor for complications of major head and neck surgery. Arch Otolaryngol Head Neck Surg 2005, 131:605-609.
67. Ferrier M.B., Spuesens E.B., Le C.S., Baatenburg de Jong R.J. Comorbidity as a major risk factor for mortality and complications in head and neck surgery. Arch Otolaryngol Head Neck Surg 2005, 131:27-32.
68. Derks W., De Leeuw J.R., Hordijk G.J., Winnubst J.A. Elderly patients with head and neck cancer: short-term effects of surgical treatment on quality of life. Clin Otolaryngol Allied Sci 2003, 28:399-405.
69. Sanabria A., Carvalho A.L., Melo R.L., et al. Predictive factors for complications in elderly patients who underwent head and neck oncologic surgery. Head Neck 2008, 30:170-177.
70. Audisio R.A., Pope D., Ramesh H.S., et al. Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. Crit Rev Oncol Hematol 2008, 65:156-163.
71. Serletti J.M., Higgins J.P., Moran S., Orlando G.S. Factors affecting outcome in free-tissue transfer in the elderly. Plast Reconstr Surg 2000, 106:66-70.
72. Werner J.A., Dunne A.A., Folz B.J., Lippert B.M. Transoral laser microsurgery in carcinomas of the oral cavity, pharynx, and larynx. Cancer Control 2002, 9:379-386.
73. Yamauchi K., Fujioka Y., Kohno N. Sentinel node navigation surgery versus observation as a management strategy for early tongue carcinoma. Head Neck 2012, 34:568-572.
74. Ambrosch P. The role of laser microsurgery in the treatment of laryngeal cancer. Curr Opin Otolaryngol Head Neck Surg 2007, 15:82-88.
75. Lefebvre J.L. Laryngeal preservation in head and neck cancer: multidisciplinary approach. Lancet Oncol 2006, 7:747-755.
76. Grenman R., Chevalier D., Gregoire V., Myers E., Rogers S. Treatment of head and neck cancer in the elderly: European Consensus (panel 6) at the EUFOS Congress in Vienna 2007. Eur Arch Otorhinolaryngol 2010, 267:1619-1621.
77. Chick L.R., Walton R.L., Reus W., Colen L., Sasmor M. Free flaps in the elderly. Plast Reconstr Surg 1992, 90:87-94.
78. Malata C.M., Cooter R.D., Batchelor A.G., Simpson K.H., Browning F.S., Kay S.P. Microvascular free-tissue transfers in elderly patients: the leeds experience. Plast Reconstr Surg 1996, 98:1234-1241.
79. Tarsitano A., Pizzigallo A., Sgarzani R., Oranges C.M., Cipriani R., Marchetti C. Head and neck cancer in elderly patients: is microsurgical free-tissue transfer a safe procedure?. Acta Otorhinolaryngol Ital 2012, 32:371-375.
80. Shestak K.C., Jones N.F. Microsurgical free-tissue transfer in the elderly patient. Plast Reconstr Surg 1991, 88:259-263.
81. Bonawitz S.C., Schnarrs R.H., Rosenthal A.I., Rogers G.K., Newton E.D. Free-tissue transfer in elderly patients. Plast Reconstr Surg 1991, 87:1074-1079.
82. Blackwell K.E., Azizzadeh B., Ayala C., Rawnsley J.D. Octogenarian free flap reconstruction: complications and cost of therapy. Otolaryngol Head Neck Surg 2002, 126:301-306.
83. Shestak K.C., Jones N.F., Wu W., Johnson J.T., Myers E.N. Effect of advanced age and medical disease on the outcome of microvascular reconstruction for head and neck defects. Head Neck 1992, 14:14-18.
84. Bridger A.G., O'Brien C.J., Lee K.K. Advanced patient age should not preclude the use of free-flap reconstruction for head and neck cancer. Am J Surg 1994, 168:425-428.
85. Shaari C.M., Buchbinder D., Costantino P.D., Lawson W., Biller H.F., Urken M.L. Complications of microvascular head and neck surgery in the elderly. Arch Otolaryngol Head Neck Surg 1998, 124:407-411.
86. Pompei S., Tedesco M., Pozzi M., Varanese A., Barile A., Marzetti F. Age as a risk factor in cervicofacial reconstruction. J Exp Clin Cancer Res 1999, 18:209-212.
87. Schofield C.P., Sykes A.J., Slevin N.J., Rashid N.Z. Radiotherapy for head and neck cancer in elderly patients. Radiother Oncol 2003, 69:37-42.
88. Allal A.S., Maire D., Becker M., Dulguerov P. Feasibility and early results of accelerated radiotherapy for head and neck carcinoma in the elderly. Cancer 2000, 88:648-652.
89. Huguenin P., Sauer M., Glanzmann C., Lutolf U.M. Radiotherapy for carcinomas of the head and neck in elderly patients. Strahlenther Onkol 1996, 172:485-488.
90. Schilcher B., Curschmann J. Clinical results of radiotherapy in 140 elderly patients treated at Basel University Hospital between 1980 and 1985. Int J Radiat Oncol Biol Phys 1995, 33:774.
91. Oguchi M., Ikeda H., Watanabe T., et al. Experiences of 23 patients > or = 90years of age treated with radiation therapy. Int J Radiat Oncol Biol Phys 1998, 41:407-413.
92. Fu K.K., Pajak T.F., Trotti A., et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000, 48:7-16.
93. Horiot J.C., Le F.R., N'Guyen T., et al. Hyperfractionated compared with conventional radiotherapy in oropharyngeal carcinoma: an EORTC randomized trial. Eur J Cancer 1990, 26:779-780.
94. Bourhis J., Overgaard J., Audry H., et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 2006, 368:843-854.
95. Baujat B., Bourhis J., Blanchard P., et al. Hyperfractionated or accelerated radiotherapy for head and neck cancer. Cochrane Database Syst Rev 2010, CD002026.
96. Nutting C.M., Morden J.P., Harrington K.J., et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011, 12:127-136.
97. Yu J.B., Soulos P.R., Sharma R., et al. Patterns of care and outcomes associated with intensity-modulated radiation therapy versus conventional radiation therapy for older patients with head-and-neck cancer. Int J Radiat Oncol Biol Phys 2012, 83:e101-e107.
98. Siddiqui F., Raben D., Lu J.J., et al. Emerging applications of stereotactic body radiation therapy for head and neck cancer. Expert Rev Anticancer Ther 2011, 11:1429-1436.
99. Siddiqui F., Patel M., Khan M., et al. Stereotactic body radiation therapy for primary, recurrent, and metastatic tumors in the head-and-neck region. Int J Radiat Oncol Biol Phys 2009, 74:1047-1053.
100. Mendenhall N.P., Malyapa R.S., Su Z., Yeung D., Mendenhall W.M., Li Z. Proton therapy for head and neck cancer: rationale, potential indications, practical considerations, and current clinical evidence. Acta Oncol 2011, 50:763-771.
101. Pignon T., Horiot J.C., Van den Bogaert W., Van G.M., Scalliet P. No age limit for radical radiotherapy in head and neck tumours. Eur J Cancer 1996, 32A:2075-2081.
102. Guo C.B., Ma D.Q., Zhang K.H., Hu X.H. Relation between nutritional state and postoperative complications in patients with oral and maxillofacial malignancy. Br J Oral Maxillofac Surg 2007, 45:467-470.
103. Ravasco P., Monteiro-Grillo I., Marques V.P., Camilo M.E. Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy. Head Neck 2005, 27:659-668.
104. Paccagnella A., Morello M., Da Mosto M.C., et al. Early nutritional intervention improves treatment tolerance and outcomes in head and neck cancer patients undergoing concurrent chemoradiotherapy. Support Care Cancer 2010, 18:837-845.
105. Chen A.M., Li B.Q., Lau D.H., et al. Evaluating the role of prophylactic gastrostomy tube placement prior to definitive chemoradiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2010, 78:1026-1032.
106. Lee H., Havrila C., Bravo V., et al. Effect of oral nutritional supplementation on weight loss and percutaneous endoscopic gastrostomy tube rates in patients treated with radiotherapy for oropharyngeal carcinoma. Support Care Cancer 2008, 16:285-289.
107. Argiris A. Induction chemotherapy for head and neck cancer: will history repeat itself?. J Natl Compr Canc Netw 2005, 3:393-403.
108. Bhide S.A., Ahmed M., Barbachano Y., Newbold K., Harrington K.J., Nutting C.M. Sequential induction chemotherapy followed by radical chemo-radiation in the treatment of locoregionally advanced head-and-neck cancer. Br J Cancer 2008, 99:57-62.
109. Forastiere A.A., Zhang Q., Weber R.S., Maor M.H., Goepfert H., Pajak T.F., et al. Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol 2013, 31(7):845-852.
110. Calais G., Pointreau Y., Alfonsi M., et al. Randomized phase III trial comparing induction chemotherapy using cisplatin (P) fluorouracil (F) with or without docetaxel (T) for organ preservation in hypopharynx and larynx cancer. Preliminary results of GORTEC 2000-01. J Clin Oncol 2006, 24(Suppl. 18):5506.
111. Hitt R., Lopez-Pousa A., Martinez-Trufero J., et al. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol 2005, 23:8636-8645.
112. Posner M.R., Hershock D.M., Blajman C.R., et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007, 357:1705-1715.
113. Vermorken J.B., Remenar E., Van Herpen C., et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 2007, 357:1695-1704.
114. Brömme J.O., Schmücking M., Arnold A., Giger R., Rauch D., Leiser D., et al. Taxane-containing induction chemotherapy followed by definitive chemoradiotherapy. Outcome in patients with locally advanced head and neck cancer. Strahlenther Onkol 2013, 189(8):618-624.
115. Trotti A., Bellm L.A., Epstein J.B., et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 2003, 66:253-262.
116. Rosenthal D.I., Lewin J.S., Eisbruch A. Prevention and treatment of dysphagia and aspiration after chemoradiation for head and neck cancer. J Clin Oncol 2006, 24:2636-2643.
117. Trotti A. Toxicity in head and neck cancer: a review of trends and issues. Int J Radiat Oncol Biol Phys 2000, 47:1-12.
118. Bentzen S.M., Rosenthal D.I., Weymuller E.A., Trotti A. Increasing toxicity in nonoperative head and neck cancer treatment: investigations and interventions. Int J Radiat Oncol Biol Phys 2007, 69:S79-S82.
119. Bentzen S.M., Trotti A. Evaluation of early and late toxicities in chemoradiation trials. J Clin Oncol 2007, 25:4096-4103.
120. Machtay M., Moughan J., Trotti A., et al. Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis. J Clin Oncol 2008, 26:3582-3589.
121. Caudell J.J., Schaner P.E., Meredith R.F., et al. Factors associated with long-term dysphagia after definitive radiotherapy for locally advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 2009, 73:410-415.
122. Kodaira T., Fuwa N., Furutani K., Tachibana H., Yamazaki T. Phase I trial of weekly docetaxel and concurrent radiotherapy for head and neck cancer in elderly patients or patients with complications. Jpn J Clin Oncol 2005, 35:173-176.
123. Bernier J., Cooper J.S., Pajak T.F., et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck 2005, 27:843-850.
124. Michal S.A., Adelstein D.J., Rybicki L.A., et al. Multi-agent concurrent chemoradiotherapy for locally advanced head and neck squamous cell cancer in the elderly. Head Neck 2012, 34:1147-1152.
125. Nguyen N.P., Vock J., Chi A., et al. Impact of intensity-modulated and image-guided radiotherapy on elderly patients undergoing chemoradiation for locally advanced head and neck cancer. Strahlenther Onkol 2012, 188:677-683.
126. Colevas A.D. Chemotherapy options for patients with metastatic or recurrent squamous cell carcinoma of the head and neck. J Clin Oncol 2006, 24:2644-2652.
127. Cohen E.E., Lingen M.W., Vokes E.E. The expanding role of systemic therapy in head and neck cancer. J Clin Oncol 2004, 22:1743-1752.
128. Gillison T.L., Chatta G.S. Cancer chemotherapy in the elderly patient. Oncology (Williston Park) 2010, 24:76-85.
129. Schneider M., Thyss A., Ayela P., Gaspard M.H., Otto J., Creisson A. Chemotherapy for patients aged over 80. Cancer in the elderly 1994, 53-60. Oxford University Press, New York.
130. Repetto L. Greater risks of chemotherapy toxicity in elderly patients with cancer. J Support Oncol 2003, 1:18-24.
131. Karamouzis M.V., Grandis J.R., Argiris A. Therapies directed against epidermal growth factor receptor in aerodigestive carcinomas. JAMA 2007, 298:70-82.
132. Bonner J.A., Harari P.M., Giralt J., et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006, 354:567-578.
133. Bonner J.A., Harari P.M., Giralt J., et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol 2010, 11:21-28.
134. Jensen A.D., Bergmann Z.P., Garcia-Huttenlocher H., Freier K., Debus J., Munter M.W. Cetuximab and radiation for primary and recurrent squamous cell carcinoma of the head and neck (SCCHN) in the elderly and multi-morbid patient: a single-centre experience. Head Neck Oncol 2010, 2:34.
135. Alongi F., Bignardi M., Garassino I., et al. Prospective phase II trial of cetuximab plus VMAT-SIB in locally advanced head and neck squamous cell carcinoma. Feasibility and tolerability in elderly and chemotherapy-ineligible patients. Strahlenther Onkol 2012, 188:49-55.
136. Burtness B., Goldwasser M.A., Flood W., Mattar B., Forastiere A.A. Phase III randomized trial of cisplatin plus placebo compared with cisplatin plus cetuximab in metastatic/recurrent head and neck cancer: an Eastern Cooperative Oncology Group study. J Clin Oncol 2005, 23:8646-8654.
137. Vermorken J.B., Mesia R., Rivera F., Remenar E., Kawecki A., Rottey S., et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med 2008, 359(11):1116-1127.
138. Stewart S, Cohen E, Licitra L, et al. A phase III randomized parallel-group study of gefi tinib (Iressa) versus methotrexate (IMEX) in patients with recurrent squamous cell carcinoma of the head and neck. Annual Meeting of the American Association of Cancer Research (AACR). Los Angeles, USA. April 14-18; 2007 [Abstr 3522].
139. Argiris A., Ghebremichael M., Gilbert J., et al. Phase III randomized, placebo-controlled trial of docetaxel with or without gefitinib in recurrent or metastatic head and neck cancer: an eastern cooperative oncology group trial. J Clin Oncol 2013, 31(11):1405-1414.
140. Vermorken J.B., Stohlmacher J., Davidenko I., et al. Primary efficacy and safety results of spectrum, a phase 3 trial in patients (pts) with recurrent and/or metastatic (r/m) squamous cell carcinoma of the head and neck (SCCHN) receiving chemotherapy with or without panitumumab (PMAB). Ann Oncol 2010, 21:12.
141. Vermorken J, Stöhlmacher J, Oliner K, et al. Safety and efficacy of panitumumab (pmab) in HPV positive (+) and HPV negative (-) recurrent/metastatic (R/M) squamous cell carcinoma of the head and neck (SCCHN): Analysis of the phase 3 spectrum trial, The 2011 European Multidisciplinary Cancer Congress; 2011.